Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Reliance Jio’s plea on Airtel ads on internet speeds dismissed August 7, 2017 Carriots IoT Platform Offers Gateway to the Digital Twin October 4, 2017 HDFC Ltd says has Rs909 crore exposure to one account identified for insolvency July 5, 2017